What is a stock summary page? Click here for an overview.
Business Description
Twist Bioscience Corp
NAICS : 339112
SIC : 8099
ISIN : US90184D1000
Description
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.28 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | -0.49 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 6.55 | |||||
| Beneish M-Score | -3.23 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 25.3 | |||||
| 3-Year EBITDA Growth Rate | -0.7 | |||||
| 3-Year EPS without NRI Growth Rate | 3.7 | |||||
| 3-Year FCF Growth Rate | 25.5 | |||||
| 3-Year Book Growth Rate | -11.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 23.13 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 18.89 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.72 | |||||
| 9-Day RSI | 39.19 | |||||
| 14-Day RSI | 42.06 | |||||
| 3-1 Month Momentum % | -16.46 | |||||
| 6-1 Month Momentum % | -14.08 | |||||
| 12-1 Month Momentum % | 13.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.96 | |||||
| Quick Ratio | 4.62 | |||||
| Cash Ratio | 3.89 | |||||
| Days Inventory | 54.79 | |||||
| Days Sales Outstanding | 39.25 | |||||
| Days Payable | 13.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6 | |||||
| Shareholder Yield % | 0.33 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44.59 | |||||
| Operating Margin % | -49.54 | |||||
| Net Margin % | -59.76 | |||||
| FCF Margin % | -20.71 | |||||
| ROE % | -38.39 | |||||
| ROA % | -29.93 | |||||
| ROIC % | -47.33 | |||||
| 3-Year ROIIC % | -21.1 | |||||
| ROC (Joel Greenblatt) % | -101.61 | |||||
| ROCE % | -33.35 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 6.95 | |||||
| PB Ratio | 5.13 | |||||
| Price-to-Tangible-Book | 6.58 | |||||
| EV-to-EBIT | -11.28 | |||||
| EV-to-EBITDA | -13.28 | |||||
| EV-to-Revenue | 6.72 | |||||
| EV-to-FCF | -32.45 | |||||
| Price-to-GF-Value | 0.8 | |||||
| Price-to-Net-Current-Asset-Value | 12.16 | |||||
| Price-to-Net-Cash | 19.84 | |||||
| Earnings Yield (Greenblatt) % | -8.87 | |||||
| FCF Yield % | -2.92 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TWST
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Twist Bioscience Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 330.189 | ||
| EPS (TTM) ($) | -3.38 | ||
| Beta | 2.74 | ||
| 3-Year Sharpe Ratio | 0.17 | ||
| 3-Year Sortino Ratio | 0.28 | ||
| Volatility % | 62.94 | ||
| 14-Day RSI | 42.06 | ||
| 14-Day ATR ($) | 2.93475 | ||
| 20-Day SMA ($) | 40.8215 | ||
| 12-1 Month Momentum % | 13.14 | ||
| 52-Week Range ($) | 27.41 - 60.9 | ||
| Shares Outstanding (Mil) | 59.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Twist Bioscience Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Twist Bioscience Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Twist Bioscience Corp Frequently Asked Questions
What is Twist Bioscience Corp(TWST)'s stock price today?
The current price of TWST is $39.29. The 52 week high of TWST is $60.90 and 52 week low is $27.41.
When is next earnings date of Twist Bioscience Corp(TWST)?
The next earnings date of Twist Bioscience Corp(TWST) is 2025-05-02 Est..
Does Twist Bioscience Corp(TWST) pay dividends? If so, how much?
Twist Bioscience Corp(TWST) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers